Clearside Biomedical, Inc.
USD0.41
+0.00 (+0.00%)
CEO
George Lasezkay
IPO Date
2016-06-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.41
Prev. Close
$0.41
Day Low
$0.41
Day High
$0.41
52W Low
$0.31
52W High
$17.10
Market Cap
$0.00B
Volume
2.05M
| -2.2 |
| 31 Dec 2022 | FY | 84.6% | -2482.8% | -310.6% | -64.2% | 3.32 | 8.54 | -2.0 |
| 31 Dec 2021 | FY | 100.0% | 1.3% | 1.0% | 0.9% | 0.02 | 9.08 | 427.8 |
| 31 Dec 2020 | FY | 100.0% | -230.7% | -207.8% | -94.2% | 0.23 | 1.82 | -7.0 |
| 31 Dec 2019 | FY | 100.0% | -1416.0% | -275.8% | -114.9% | 0.57 | 2.31 | -3.6 |
| 31 Dec 2018 | FY | 100.0% | -276060.0% | -350.6% | -187.7% | 0.42 | 4.10 | -0.4 |
| 31 Dec 2017 | FY | 100.0% | -17094.2% | -275.4% | -145.6% | 0.37 | 2.90 | -3.0 |
| 31 Dec 2016 | FY | 100.0% | -4977.3% | -36.1% | -30.5% | 0.11 | 15.59 | -4.5 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -165.5% | -83.8% | 0.56 | 3.94 | -5.0 |
| -3.5 |
| 31 Mar 2025 | Q1 | 89.4% | -352.9% | 17.9% | -41.8% | -1.18 | 3.19 | -2.1 |
| 31 Dec 2024 | Q4 | 51.3% | -2387.6% | 18.8% | -29.1% | -1.35 | 4.44 | -2.5 |
| 30 Sept 2024 | Q3 | 100.0% | -740.7% | 22.1% | -26.4% | -1.44 | 4.49 | -3.1 |
| 30 Jun 2024 | Q2 | 100.0% | -8437.8% | 26.8% | -22.4% | -1.68 | 5.07 | -3.1 |
| 31 Mar 2024 | Q1 | 87.8% | -5114.3% | 53.9% | -29.3% | -2.08 | 6.07 | -2.3 |
| 31 Dec 2023 | Q4 | 99.7% | -76.2% | 30.4% | -14.2% | -2.70 | 4.42 | -3.8 |
| 30 Sept 2023 | Q3 | 83.5% | -1078.8% | 72.1% | -26.9% | -0.08 | 5.28 | -1.5 |
| 30 Jun 2023 | Q2 | 79.1% | -894.5% | 183.1% | -23.2% | -0.23 | 6.85 | -1.9 |